tegafur has been researched along with Hyperlipemia in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 36-year-old woman was treated with tamoxifen for lung metastasis of breast cancer and had marked hyperlipoproteinemia with giant fatty liver, high plasma triglyceride levels (3673 mg/dl), and increased levels of very low density lipoprotein (VLDL) and intermediate density lipoprotein (UDL)." | 7.67 | [A case report of hyperlipemia with giant fatty liver during adjuvant endocrine therapy by tamoxifen]. ( Kitabayashi, K; Koshino, Y; Mabuchi, H; Miyazaki, I; Nakano, Y; Noguchi, M; Nonomura, A; Tajiri, K; Taniya, T, 1987) |
| "We previously reported a case where S-1, containing tegafur, gimeracil, and oteracil potassium, induced severe hypertriglyceridemia." | 5.12 | Severe hypertriglyceridemia induced by S-1: Subsequent case series of four patients and further review of the literature. ( Komatsu, Y; Saito, Y; Sugawara, M; Takekuma, Y; Takeuchi, S, 2021) |
| "A 36-year-old woman was treated with tamoxifen for lung metastasis of breast cancer and had marked hyperlipoproteinemia with giant fatty liver, high plasma triglyceride levels (3673 mg/dl), and increased levels of very low density lipoprotein (VLDL) and intermediate density lipoprotein (UDL)." | 3.67 | [A case report of hyperlipemia with giant fatty liver during adjuvant endocrine therapy by tamoxifen]. ( Kitabayashi, K; Koshino, Y; Mabuchi, H; Miyazaki, I; Nakano, Y; Noguchi, M; Nonomura, A; Tajiri, K; Taniya, T, 1987) |
| "Diabetes mellitus was diagnosed in 124 patients (50%) who had less distant metastasis and more hypertension." | 1.39 | Clinical outcomes of chemotherapy for diabetic and nondiabetic patients with pancreatic cancer: better prognosis with statin use in diabetic patients. ( Hirano, K; Ijichi, H; Isayama, H; Kawakubo, K; Kogure, H; Koike, K; Mizuno, S; Nakai, Y; Sasahira, N; Sasaki, T; Tada, M; Tateishi, K; Yamamoto, N, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Saito, Y | 1 |
| Takekuma, Y | 1 |
| Takeuchi, S | 1 |
| Komatsu, Y | 1 |
| Sugawara, M | 1 |
| Nakai, Y | 1 |
| Isayama, H | 1 |
| Sasaki, T | 1 |
| Mizuno, S | 1 |
| Sasahira, N | 1 |
| Kogure, H | 1 |
| Kawakubo, K | 1 |
| Yamamoto, N | 1 |
| Hirano, K | 1 |
| Ijichi, H | 1 |
| Tateishi, K | 1 |
| Tada, M | 1 |
| Koike, K | 1 |
| Taniya, T | 1 |
| Noguchi, M | 1 |
| Tajiri, K | 1 |
| Nakano, Y | 1 |
| Kitabayashi, K | 1 |
| Miyazaki, I | 1 |
| Koshino, Y | 1 |
| Nonomura, A | 1 |
| Mabuchi, H | 1 |
1 review available for tegafur and Hyperlipemia
| Article | Year |
|---|---|
Severe hypertriglyceridemia induced by S-1: Subsequent case series of four patients and further review of the literature.
Topics: Humans; Hyperlipidemias; Hypertriglyceridemia; Oxonic Acid; Pyridines; Tegafur; Triglycerides | 2021 |
2 other studies available for tegafur and Hyperlipemia
| Article | Year |
|---|---|
Clinical outcomes of chemotherapy for diabetic and nondiabetic patients with pancreatic cancer: better prognosis with statin use in diabetic patients.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protoc | 2013 |
[A case report of hyperlipemia with giant fatty liver during adjuvant endocrine therapy by tamoxifen].
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Fatty Liver; Female; Humans; Hyperlipidemias; Lung Neoplasm | 1987 |